Navigation Links
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
Date:6/17/2011

in the United States dedicated solely to mental health. Janssen currently markets prescription medications for the treatment of schizophrenia, Bipolar 1 Disorder, and schizoaffective disorder. Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a member of the Johnson & Johnson Family of Companies. For more information about Janssen, visit http://www.janssen.com.

About Patriot Pharmaceuticals, LLCPatriot Pharmaceuticals, LLC is a wholly owned subsidiary of Ortho-McNeil-Janssen Pharmaceuticals, Inc.  The company markets and distributes authorized generic pharmaceuticals, including itraconazole, ketoconazole, galantamine, Tramadol HCl ER 100mg and 200mg and risperidone. Patriot is located in Horsham, PA.

Important Safety Information About RISPERDAL® and Risperidone Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. RISPERDAL® (risperidone) is not approved for the treatment of patients with dementia-related psychosis.

The most common adverse reactions observed in all clinical trials with RISPERDAL® occurring at a rate of at least 10% were drowsiness, increased appetite, fatigue, insomnia, sedation, tremor, muscle stiffness , vomiting, coughing, constipation, stuffy nose,  runny nose, drooling, dry mouth, abdominal pain, dizziness, nausea, anxiety, headache, nasal congestion , common cold, rash, and restlessness.

Neuroleptic Malignant Syndrome (NMS) is a rare and potentially fatal side effect reported with RISPERDAL® and similar medicines. Call your doctor immediately if the person being treated develops symptoms such as high fever; stiff muscles; shaking; confusion; sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness. Treatment should be stopped if the person being treated has
'/>"/>

SOURCE Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
2. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
3. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
4. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
5. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
6. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
7. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
8. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
9. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
10. Aeolus Pharmaceuticals, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: ... a company overview at the UBS Global Healthcare Conference in ... for Wednesday, May 22 nd at 11 a.m. Eastern ... of the presentation, please visit the Investor Relations section of ... will be available for 14 days after the event. ...
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ("Sony") ... 8-well strip holder and 130um sorting chip.  Sony will also ... on its new SH800 Cell Sorter, the EC800 flow cytometer, ... tutorials at CYTO 2013, which will be held at the ... San Diego, California , from May 20 - ...
(Date:5/17/2013)... 2013 Research explores data ... research also   to   be presented ... ), the global specialty biopharmaceutical company, announces that it ... the American Psychiatric Association (APA) 166th Annual Meeting in ... data being presented represent Shire,s ongoing commitment to the ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
(Date:5/18/2013)... (May 19, 2013) Each year, the American ... outstanding contributions and achievements in gastroenterology through its ... many distinguished and talented individuals who work tirelessly ... Today, we are pleased to announce the 2013 ... their colleagues for their tremendous contributions to our ...
(Date:5/18/2013)... 2013 Illuminations is proud to present the ... Seminars will take place over the course of four days, ... and Saturday, June 8, 2013. , Inner Child Therapy is ... on the attitudes, patterns and coping mechanisms that create the ... learn to live a more integrated and balanced life style, ...
(Date:5/18/2013)... MOOSGO.COM published an original art book for iPad ... group of artists who share their creations based on the ... Exclusively for iPad . , This work gathers ... that reflect the signature idiosyncrasy and passion of tango. Such ... Store and it includes a free trailer of the ...
(Date:5/18/2013)... In a May 14, 2013 article ... After Discovering Cancer Gene,” Fox News reported the movie ... that she carried a gene that doctors estimated gave ... a 50 percent risk of ovarian cancer (go to: ... 16, 2013 with a blog post entitled “A Patient’s ...
(Date:5/18/2013)... Transvaginal mesh lawsuits involving ... forward in a consolidated litigation underway in New Jersey’s ... to a notice on the Court’s website, the next ... will be held on Wednesday, May 22nd. Court ... the proceeding on behalf of women who suffered serious ...
Breaking Medicine News(10 mins):Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5Health News:Illuminations Brings World Renowned Therapist to the Middle East 2Health News:New Art Book for iPad: Tango Art 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3
... , MONDAY, Nov. 2 (HealthDay News) -- Though someone ... lack basic knowledge about the potentially life-threatening disease, according ... , Diabetes is responsible for more deaths each year ... combined, but just 42 percent of those surveyed knew ...
... SINGAPORE, Nov. 2 /PRNewswire-Asia/ -- GfK Asia releases ... line with the,17th Hong Kong Optical Fair, hosted by Hong ... 2009 include China, Hong Kong, Korea,Singapore and Malaysia. The survey ... or the same in 2010. , ...
... cocoa, snuggling under blankets and heart attacks all have in ... months. , According to the Centers for Disease Control ... heart attack or similar cardiac event during or after a ... create awareness, work to lower that number, and highlight other ...
... professional athletes, who wear helmets in their careers, to help ... NEW YORK, Nov. 2 November is Epilepsy Awareness Month. ... American Epilepsy Outreach Foundation (AEOF) has joined with ... 1st Annual Helmets for Hope(TM) Campaign. The Helmets for Hope(TM) ...
... 2 In a dramatic settlement seen as a novel ... professional association, and one of the country,s biggest hospital systems ... on containing the spread of pandemics such as H1N1 "swine ... new course for limiting the spread of not only swine ...
... Preliminary evaluation after completion of treatment phase shows that, ... for patients with advanced-stage, platinum-resistant, taxane-pretreated ... AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS ) ... therapy and oncology, today announced positive efficacy data from ...
Cached Medicine News:Health News:Americans Get Failing Grade on Diabetes Awareness 2Health News:Americans Get Failing Grade on Diabetes Awareness 3Health News:Asian Optical Retailers Upbeat about 2010 2Health News:Asian Optical Retailers Upbeat about 2010 3Health News:MTD Joins Forces with the AHA to Promote Heart Health 2Health News:Helmets for Hope Campaign and Gala 2Health News:Dramatic Settlement Sets National Model for H1N1 Hospital Safety Measures 2Health News:Dramatic Settlement Sets National Model for H1N1 Hospital Safety Measures 3Health News:AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 2Health News:AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 3Health News:AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 4
... Multi-Use Reposable Clip Applier ... disposables with the economics ... superior instrument balance and ... cartridges. The multi-use Reposable ...
Finally, security and dependability in an automatic 5mm clip applier!...
Pilling-Weck, medium-large clip size, 10mm, rotatable take apart...
Insert only, Pilling-Weck small clip size...
Medicine Products: